• About
  • Submit Article/PR
  • Contact
Monday, March 27, 2023
No Result
View All Result
  • Login
The Healthcare Daily
WHO COVID DASHBOARD
  • Home
  • News
    • All
    • Biotech
    • By Speciality
    • Generic Drugs
    • Insurance
    • Investment
    • Medical Tourism
    • Pharma
    What-Chronic-Disease-Management-Is-All-About-How-to-Deal-with-It-Healthcare-Daily

    What Chronic Disease Management Is All About & How to Deal with It

    cancer-cure-TheHealthcareDaily

    Cancer Cure: Is there a cure for it?

    Womens-Reproductive-Rights-Around-the-world-Healthcare-Daily

    Women’s Reproductive Rights Around the World : Rights 101

    Everything-about-Telehealth-reimbursement-and-insurance-coverage-Healthcare-Daily

    Absolutely Everything about Telehealth Reimbursement and Coverage : Healthcare 101

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    Everything about Personalized Medicine in 2023

    Healthcare cost containment and insurance reform

    Healthcare cost containment and insurance reform

    Understanding Chronic Diseases: Symptoms, Causes, and Treatment Options

    The Most Common Dental Mistakes in Healthcare Industry

    The 6 Most Common Dental Mistakes in Healthcare Industry

    How To Get a Dental Checkup for Free (or Cheap)

    How To Get a Dental Checkup for Free (or Cheap)

  • Insights
    • All
    • Analysis
    • Interview
    • Opinion
    • Reports
    Workforce-Diversity-and-its-5-Benefits-in-healthcare-Daily

    Workforce Diversity and it’s 5 Benefits in healthcare

    Healthcare-Affordability-in-United-States-Healthcare-101-Daily

    Healthcare Affordability in United States : Healthcare 101

    The-Benefits-and-Challenges-of-Data-and-Analytics-in-Healthcare-Daily

    The Benefits and Challenges of Data and Analytics in Healthcare

    Healthcare-Industry-At-A-Glance-Healthcare-DAily

    Healthcare Industry At A Glance

    7-Reasons-Millennials-Are-The-Most-Disruptive-Generation-Yet-Healthcare-Daily

    7 Reasons Millennials Are The Most Disruptive Generation Yet

    Technological-challenges-faced-by-pharma-companies-today-Healthcare-Daily

    Technological challenges faced by Pharma Companies Today

    Senior living options in Canada

    Senior living options in Canada in 2022

    A Guide to Medical Tourism in India: Everything You Need to Know

    A Guide to Medical Tourism in India: Everything You Need to Know

    5 Things to know before adopting a child

    Adoption: 5 Things to know before going for a successful child adoption

  • HealthTech
    • All
    • Hardware
    • Innovation
    • Software
    Overview-of-healthcare-hackathons-and-competitions-focused-on-healthcare-innovation-thehealthcaredaily

    Overview of healthcare hackathons and competitions focused on healthcare innovation

    Everything-about-Telehealth-reimbursement-and-insurance-coverage-Healthcare-Daily

    Absolutely Everything about Telehealth Reimbursement and Coverage : Healthcare 101

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    Everything about Personalized Medicine in 2023

    5-Amazing-Advancements-in-Medical-Technology-2023-Healthcare-Daily

    5 Amazing Advancements in Medical Technology 2023

    Pros-and-Cons-of-Telemedicine-Healthcare-Daily

    Pros and Cons of Telemedicine in Healthcare 2023

    The-Benefits-and-Challenges-of-Data-and-Analytics-in-Healthcare-Daily

    The Benefits and Challenges of Data and Analytics in Healthcare

    Healthcare workforce and talent management

    Healthcare workforce and talent management

    Healthcare cost containment and insurance reform

    Healthcare cost containment and insurance reform

    Telehealth and digital health solutions

    Telehealth and digital health solutions

  • Pharma
  • Events
  • NewsMakers
  • World
  • Home
  • News
    • All
    • Biotech
    • By Speciality
    • Generic Drugs
    • Insurance
    • Investment
    • Medical Tourism
    • Pharma
    What-Chronic-Disease-Management-Is-All-About-How-to-Deal-with-It-Healthcare-Daily

    What Chronic Disease Management Is All About & How to Deal with It

    cancer-cure-TheHealthcareDaily

    Cancer Cure: Is there a cure for it?

    Womens-Reproductive-Rights-Around-the-world-Healthcare-Daily

    Women’s Reproductive Rights Around the World : Rights 101

    Everything-about-Telehealth-reimbursement-and-insurance-coverage-Healthcare-Daily

    Absolutely Everything about Telehealth Reimbursement and Coverage : Healthcare 101

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    Everything about Personalized Medicine in 2023

    Healthcare cost containment and insurance reform

    Healthcare cost containment and insurance reform

    Understanding Chronic Diseases: Symptoms, Causes, and Treatment Options

    The Most Common Dental Mistakes in Healthcare Industry

    The 6 Most Common Dental Mistakes in Healthcare Industry

    How To Get a Dental Checkup for Free (or Cheap)

    How To Get a Dental Checkup for Free (or Cheap)

  • Insights
    • All
    • Analysis
    • Interview
    • Opinion
    • Reports
    Workforce-Diversity-and-its-5-Benefits-in-healthcare-Daily

    Workforce Diversity and it’s 5 Benefits in healthcare

    Healthcare-Affordability-in-United-States-Healthcare-101-Daily

    Healthcare Affordability in United States : Healthcare 101

    The-Benefits-and-Challenges-of-Data-and-Analytics-in-Healthcare-Daily

    The Benefits and Challenges of Data and Analytics in Healthcare

    Healthcare-Industry-At-A-Glance-Healthcare-DAily

    Healthcare Industry At A Glance

    7-Reasons-Millennials-Are-The-Most-Disruptive-Generation-Yet-Healthcare-Daily

    7 Reasons Millennials Are The Most Disruptive Generation Yet

    Technological-challenges-faced-by-pharma-companies-today-Healthcare-Daily

    Technological challenges faced by Pharma Companies Today

    Senior living options in Canada

    Senior living options in Canada in 2022

    A Guide to Medical Tourism in India: Everything You Need to Know

    A Guide to Medical Tourism in India: Everything You Need to Know

    5 Things to know before adopting a child

    Adoption: 5 Things to know before going for a successful child adoption

  • HealthTech
    • All
    • Hardware
    • Innovation
    • Software
    Overview-of-healthcare-hackathons-and-competitions-focused-on-healthcare-innovation-thehealthcaredaily

    Overview of healthcare hackathons and competitions focused on healthcare innovation

    Everything-about-Telehealth-reimbursement-and-insurance-coverage-Healthcare-Daily

    Absolutely Everything about Telehealth Reimbursement and Coverage : Healthcare 101

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    Everything about Personalized Medicine in 2023

    5-Amazing-Advancements-in-Medical-Technology-2023-Healthcare-Daily

    5 Amazing Advancements in Medical Technology 2023

    Pros-and-Cons-of-Telemedicine-Healthcare-Daily

    Pros and Cons of Telemedicine in Healthcare 2023

    The-Benefits-and-Challenges-of-Data-and-Analytics-in-Healthcare-Daily

    The Benefits and Challenges of Data and Analytics in Healthcare

    Healthcare workforce and talent management

    Healthcare workforce and talent management

    Healthcare cost containment and insurance reform

    Healthcare cost containment and insurance reform

    Telehealth and digital health solutions

    Telehealth and digital health solutions

  • Pharma
  • Events
  • NewsMakers
  • World
No Result
View All Result
The Healthcare Daily
No Result
View All Result

MicroOptx Completes Patient Enrollment in Initial Phase of U.S. Pivotal Clinical Trial for the Beacon Aqueous Microshunt

by Aanchal Shalini Pundir
August 3, 2020
in Press Release
Reading Time: 3 mins read
0
0
SHARES
Share on FacebookShare on Twitter

MINNEAPOLIS, July 30, 2020 /PRNewswire/ — MicroOptx Inc., a medical device innovator with a platform technology to change the way the world treats glaucoma, today announced the completion of enrollment in the initial phase of the Beacon Study. This is the U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) clinical trial of the Beacon Aqueous Microshunt. Study participants treated during the initial phase of the interventional, single-arm, open label, multicenter clinical trial will be followed to evaluate safety, performance, and intraocular pressure (IOP) reduction. These results will form the basis of trial expansion to include a total of 90 implanted eyes. The primary effectiveness outcome will be intraocular pressure (IOP) reduction. 

The Beacon device distinguishes itself from other implantable glaucoma devices in that it lowers and controls IOP by shunting aqueous humor (AH) directly to the tear film rather than an enclosed space inside the eye. This approach allows more precise and consistent IOP control that may help regulate the progression of glaucoma. The implant procedure involves a 1.4mm incision followed by simple insertion of the device into the anterior chamber. It is designed for use in patients with their natural lens and those in which the natural lens has been removed and replaced with an artificial lens. The U.S. pivotal clinical trial is only for refractory glaucoma patients undergoing a standalone procedure, though multiple concomitant (with cataract surgery) procedures have been performed in an otherwise similar European study. 

In addition to the U.S. pivotal clinical trial to evaluate the Beacon device, MicroOptx is also conducting the Early BiRD (EU) trial at investigational centers in Europe. It is ongoing with about 25 percent of study participants beyond their 1-year follow-up. Results of the initial cohort have been published in the most recent issue of the Journal of Cataract and Refractive Surgery. MicroOptx has also completed enrollment in its U.S. feasibility study that is being conducted under an IDE as part of the FDA’s Early Feasibility Studies program. The longest follow-up duration available from this study is two years. 

“The Beacon device represents the next generation in Micro-Invasive Glaucoma Surgery devices, or MIGS, striving for trabeculectomy effectiveness without the complications and required maintenance,” said Chris Pulling, MicroOptx Chief Executive Officer. “Completion of enrollment in the initial phase of the Beacon clinical trial marks achievement of an important milestone in bringing this transformative therapy to patients and providers. To achieve this milestone, in just over one month and in the current COVID environment, is a testament to the great team at MicroOptx and the enthusiasm of our clinician partners and the patients they care for.”

Glaucoma is characterized by progressive, irreversible and largely asymptomatic vision loss caused by optic nerve damage. There is no cure for this disease, and reducing intraocular pressure is the only proven treatment. According to Market Scope, approximately 80 million people worldwide have glaucoma, including 4.5 million people in the United States. The vast majority of glaucoma sufferers worldwide currently have no access to any effective therapy and are needlessly blind or going blind.

The Beacon device is an investigational, first-generation device. MicroOptx is currently pursuing its initial regulatory approvals to commercialize the device in the United States, Canada, and the European Union.

About MicroOptx
MicroOptx (www.microoptx.com) is an ophthalmic medical technology company focused on the development and commercialization of platform technology that shunts aqueous humor to the surface of the eye. Its current focus is to use this technology to create a safe, simple, transformative treatment for glaucoma – the world’s leading cause of irreversible blindness – by normalizing intraocular pressure at a range low enough to halt the progression to blindness for most glaucoma patients. The company expects European market approval in 2021 and U.S. and Canada market approval in 2022.

SOURCE MicroOptx

Related Links

https://microoptx.com/

Aanchal Shalini Pundir

Aanchal Shalini Pundir

Aanchal is currently managing the NGO Sarvani in Chandigarh after returning from what can only be described as a life changing experience in the valley of Uttarakhand. An avid reader, social worker and wanderer, she is only interested in conversations revolving around Amrita Pritam, Manto, Faiz and Chai.

Next Post

Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes

Recommended

U.S. FDA recommends GSK unit’s long-acting HIV vaccination

U.S. FDA recommends GSK unit’s long-acting HIV vaccination

2 years ago
Regardless of their Genes women who exercise may livelonger

Women who exercise regardless of their good or poor genes may live longer

7 months ago

About Us

A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.

Contact Us

Medianiti Ltd, Brooklands Business Park, Wellington Way, Weybridge KT13 0TT,
United Kingdom
General: hello@thehealthcaredaily.com

Important Links

  • Home
  • World
  • Business
  • Health

Recent News

Exploring innovative approaches to healthcare delivery in developing countries

Comparing healthcare systems in different countries and the unique challenges they face

  • About
  • Submit Article/PR
  • Contact

© 2020 THP - A Medianiti Venture.

No Result
View All Result
  • Home
  • World
  • Business
  • Health

© 2020 THP - A Medianiti Venture.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In